##
##
##
|The members|of the Board who|served as agents
for the Corporate
Trustee
during|the|financial|year were|
|---|---|---|---|---|---|
|correctly diedosed as fogows:||||||
|Derek Bell||Joint Chairman||||
|Jugs Ann Gilfon||Chief Executive to31st March 2D23||||
|Anandapuram|Deepak Dwarakanath|Chief Medical Officer to21stSeptember 2023 /Deputy||Chief Executive to||
|||30th September 2023||||
|Elaine Gook||Interim Chief Medical Officer from 22nd September|2023|||
|Alan Sheppard||Chief People Officer to 31stAugust 2022||||
|Neil Atkinson||Managing
Director from 1st April 2023||||
|Graham
Evans||Chief Information
Technology
Officer to31st May 2022||||
|Levl Bucklay||Chief Operating
Officer to 3Dth Apdf 2023||||
|Stephen
Hall||Vice Chairman
and hfon-executive
Director to 31st|March 2023|||
|Ann Baxter||Vice Chair from 1 April 2023||||
|Lfndsey Robertson||Chief Nuse/Director
of Patient Safety end Quality||||
|Linda Hunter||Director of Planning
&Performance||||
|Graham
Walton||Non-executive
Director to 17th March 2023||||
|Christopher
Macklin||Non-executive
Director||||
|Gglian Colquhoun||Chief Informsffon
8 Technology
Offfcer from 30th May 2022 to 30th June||||
|||2023||||
|Ken Anderson||Chief fnformation 8 Technology
Offfcer from 30th October 2023||||
|Suey Cook||Chief People Office/Director
ofCorporate Affairs||||
|Fey Scugion||Norvexacutlve
Director||||
|lsn Simpson||Chair of NTH Solutions LLP and Optimus
Limited Company
(Non-||||
|||Execulive Director)||||
|James Bromiley||Norvexecutive
Director from 1st February 2023to 31stJuly 2023||||
|Algeon Fellows||Non-executive
Director||||
|Elizabeth Bames||Non-executive
Direrlor fmm 1st February 2023||||
|Kate Hudson-Hslliday||Acting Director of Finance from 1stJune 2023||||
|Rowena Dean||Acting Chief Operating
ONcer from 24th April 2023||||
|Michaef Houghton||Director ofTransformation
from 1Dth July 2023||||
|Stuart Iivlne||Director ofStrategy, Assurance
&Compliance
from|1Dlh July 2023|||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||m||E|
|---|---|---|---|---|---|
|Paxman
cooling ceps to prevent|hair loss during chemotherapy|treatment||34||
|Anetic aid patient trolley stroke|unit|||7||
|Vien viewer flex Hasmatology||||5||
|Benevision
N1 Monitor Stroke unit||||5||
|Other medical eqvipmenl||||||
|||||57||
##
##
|ajor refurbishm|ents
and ITequipment
purchases
during
Ihe y|ear are shown b|elow:||
|---|---|---|---|---|
||||~Edll|rra|
|Touchscreen|devices, trolley and software used by dementia|patients|||
|Refurbishment|urology room||||
|Other refurbishment
costs|||||
||||15||
|Staff|training|67|
|---|---|---|
|Other|staff welfare|30|
|||97|
##
|Staff lottery|winnings
paid||29|
|---|---|---|---|
|Statf lottery|administration|costs|1|
|Fundralsing|Events costs||18|
|Fundraising|salary recharge costs||42|
||||90|
##
##
##
##
##
##
##
##
##
|Funds managed|by CCLA|For Charities are|as follows:||
|---|---|---|---|---|
|Equities|||f000||
|COIF Charities|Investment|Fund|1,414|100|
|Total|||1,414|100|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|
|||||Note|Unreslrided|Restricted|Funds|Funds|
||||||Funds|Funds|2022/23|2021/22|
||||||8000|8000|8000|EDOO|
|Income and endowments||from:|||||||
|Donations||||3|458|110|568|498|
|Legacies||||3||||'I61|
|Charitable
activities||||4||3'I|3'I|41|
|Other trading
activities-Fundraising|||Events- Staff lottery|5|5|43|48|43|
|Other incoming
resources||||6|6|9|15|5|
|Investment
Income||||13.3|23|18|41|41|
|Total incoming
resources|||||492|211|703|789|
|Expenditure
on:|||||||||
|Raising Funds|||||60|30|90|55|
|Charitable
activities:|||||||||
|Research Posts and Clinical||Care||||37|37|4|
|Pumhsse of Equipment||||||57|57|'ID7|
|Refurbishment
costs|||||1|14|15|22|
|Staff Education
and Welfare|||||20|77|97|70|
|Patient Welfare|||||16|25|41|41|
|Governance
Costs||||10|23|18|41|37|
|Total expenditure|||||120|258|378|336|
|Net (loss)/gain
an Investments||||13.1~31||~24|~55|118|
|Net income/(expenditure)|before transfers||||341|(71)|270|571|
|Transfers between
funds||||16|(95)|95|||
|Net movement
in funds||||18|246|24|270|571|
|Fund balances brought farwsrd at 1 April|||||1,392|1,225|2,617|2,046|
|Fund balances carried forward at 31 March|||||'I,838|1,249|2,887|2,617|
|Balance Sheet as at|31 March 2023||||||
|---|---|---|---|---|---|---|
|||Note|Unrestricted|Restricted|Total at 31|Tata Iat31|
||||Funds|Funtie|March 2023|March 2022|
||||f000|f000|EOOO|f000|
|Fixed Assets|||||||
|Investments||13|695|719|1414|1469|
|Total fixed assets|||695|719|1,414|1,469|
|Current Assets|||||||
|Stocks|||||||
|Debtors and accrued income||14||11|11|12|
|Cash and cash equivalents|||966|009|1 555|1 241|
|Total current assets|||966|600|1,5|1,209|
|Current gabilitles|||||||
|Creditors: amounts|falling due||||||
|within one year||15|23|70|93|111|
|Net current assets|||943|530|1,473|1,148|
|Total assets lass current liabgitles|||1.638|1.249|2,887|2,617|
|Net Assets|||1,638|1,249|2,887|2,617|
|The funds ofthe Charity|||||||
|Restricted Income funds||||1,249|1,249|1,225|
|Unrestricted
income|funds||1,638||'i,638|1,392|
|Total Charity Funds||19|1,638|1,249|2,887|2,617|
##
##
|||||||Note|||
|---|---|---|---|---|---|---|---|---|
||||||||2022I23|2021/22|
||||||||6000|6000|
|Cash tlows from operating|||activitiles:||||||
|Net cash from operating||activities||||18|267|686|
|Cash flows from investing|||activities:||||||
|Dividends|and Interest from||Investmenls|||13.3|41|41|
|Proceeds|from sale ofinvestments||||||||
|Net cash|provided
by investing
activities||||||41|41|
|Change|in cash and cash||equivalents|In the reporting|period||308||
|Increase|in cash and cash|equivalents||in the year|||308|727|
|Cash and|cash equivalents||at ihe bsg!nnlng of||||||
|repcrling|period||||||1,247|520|
|Total cash and cash equivalents
st the end|||||||1,555|1,247|
|ofthe year|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|3.Voluntar|y
Income||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2022/23|2021/22|
||||EOOD|EOOD|EOOD|EOOD|
|Donations|||2|97|99|91|
|Fundrsising|Income Generated|by Individuals|16|1'I|27|14|
|Grants Receivable|||97||97|27|
|Corporate|Donations||338||338|362|
|Gift Aid|||5||7|4|
|Legacies||||||161|
|Total|||458|110|568|659|
##
|The income|was primarily
from the provis|ion oftraining courses
in|furtherance
ofthe|Charity's objective|s.|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||Funds|Funds|2D22/23|2021/22|
|||EOOO|EOOO|EOOD|EOOD|
|Income from|the provision|||||
|ofeducation|and training||31|31|41|
|Total|||31|31|41|
|5.Other Trading Activities||||||
|||Unrestricted|Restricted|Total|Total|
|||Funds|Funds|2022/23|2D21/22|
|||EOOO|FOOD|EDOO|EOOD|
|Staff Lottery|deductions||43|43|40|
|Fundraising|Events|||5|3|
|Total||||||
|6. Other Incoming Resources||||||
|||Unrestricted|Restricted|Total|Total|
|||Funds|Funds|2022/23|2D21/22|
|||EOOD|EOOD|EOOD|EOOD|
|Other Income||6|9|15|5|
|Total|||9|15|5|
##
##
|7.Raising F|unds|||||
|---|---|---|---|---|---|
|||||2022/23|2021/22|
|||||ROOD|ROOD|
|Staff Lottery|Winnings|&Admin||30|28|
|Fundraising|Expenses|||'I8|5|
|Fundraising|Salary Costs|||42|22|
|Total||||55|55|
|8.Charitable|activities|||||
|The Charity pursued
its||charitable|activities|by making grants. shown below by category.||
|||||2022/23|2021/22|
|||||EDDO|EOOD|
|Purchase of|Equipment|||57|107|
|Research Posts and Clinical Care||||37|4|
|Refurbishment|Costs &|ITEquipment||15|22|
|Staff Education
and Welfare||||97|70|
|Patients Welfare||||41|41|
|Total||||||
##
##
|10.Gov|ernance
Costs|||
|---|---|---|---|
|||2022/23|2021/22|
|||ROOD|ROD 0|
|Internal|audit|3|3|
|External|audit|9|6|
|Governance||12||
|Financial|administration|29|28|
|Total||41|37|
##
##
##
##
|The investment
is valued at bid price 2022/23 and|The investment
is valued at bid price 2022/23 and|The investment
is valued at bid price 2022/23 and|2021/22||
|---|---|---|---|---|
|13.1 Movement
In fixed asset investment|||2022/23|2021/22|
||||Total|Total|
||||6000|6000|
|Market value brought|forward||1,469|1,351|
|IVionies owed by COLA for||Charities|10|10|
|Shorl term dividends|||(10)|('I0)|
|Less disposals at carrying
Net gain on revaluation||value|~55|118|
|Market value at 31 March|||1,414|1,469|
|13.2 Market value at|31 March||2022/23|2021/22|
||||Total|Total|
||||8000|6000|
|Held in UK|||||
|COIF Charities
Investment||Fund|1,414|1,469|
|Total|||1,414|1,469|
|||||2022/23|2021/22|
|---|---|---|---|---|---|
|Asset alfocation||||||
|Overseas
Equities||||63.41%|64 13%|
|Infrastructure||&Operating|Assets|8.32'Yo|9.06%o|
|UK Equities||||8.04%|8.50%|
|Fixed Interest||||7.84%||
|Cash &near|cash|||4 76%|8.52%|
|Property||||3.10%|458%|
|Contractual|&Other Income|||1 85%|2.76%|
|Private Equity||&Other||2.66%|2.45o7o|
|Oerivatives||||O.D2%||
|||||100%|100%|
##
##
|13.3 Total gross income from invest|ments
and cash on deposit||
|---|---|---|
||2022/23|2021/22|
||Total|Total|
||ROOD|ROOD|
|Meld in UK|||
|Investments|41|41|
|Total|41|41|
##
|14.Deb|tors: amounts|faglng du|e within|one year||||
|---|---|---|---|---|---|---|---|
||||||2022/23||2021/22|
|||||||Total|Total|
|||||||RDOO|6000|
|Dividend|Income|||||11|11|
|Pre payments|||||||1|
|Accrued|Income|||||||
|Total|||||||12|
|15.Creditors: amounts||falling due within||one year||||
||||||2022/23||2021/22|
|||||||Total|Total|
|||||||ROOD|ROOD|
|Accruals||||||31|51|
|Deferred|Income|||||2|4|
|Amounts|owed to North|Tees and|Hartlepool|NHS and||||
|Trading|Companies|||||60|48|
|Foundation
Trust||||||||
|Other creditors||||||||
|Total||||||93||
|There is|no security for non-trading||amounts|owed to the|Foundation|Trust.||
|16. Transfers between||funds|||2022/23||2021/22|
|||||||Total|Total|
|||||||f000|ROOD|
|Transfers||||||95||
##
##
##
##
##
|||||2022/23|2021/22|
|---|---|---|---|---|---|
|||||Total|Total|
|||||6000|6000|
|Net movement
in funds||||270|571|
|Loss/(Gain)
on investments||||55|(118)|
|Deduct interest/dividends||income shown||||
|in investing
activiTies||||(41)|(41)|
|Decrease in debtors||||1|268|
|(Decrease)/Increase|in creditors|||(18)|6|
|Net cash generated|from|operating|activities|267|686|
##